Lajkó Eszter and Tuka Bernadett and Fülöp Ferenc and Krizbai István Adorján and Toldi József and Magyar Kálmán and Vécsei László and Kőhidai László:
Kynurenic acid and its derivatives are able to modulate the adhesion and locomotion of brain endothelial cells.
JOURNAL OF NEURAL TRANSMISSION, 125 (6).
pp. 899-912.
ISSN 0300-9564
(2018)
Szökő Éva and Tábi Tamás and Riederer Peter and Vécsei László and Magyar Kálmán:
Pharmacological aspects of the neuroprotective effects of irreversible MAO-B inhibitors, selegiline and rasagiline, in Parkinson’s disease.
JOURNAL OF NEURAL TRANSMISSION, 125 (11).
pp. 1735-1749.
ISSN 0300-9564
(2018)
Tábi Tamás and Szökő Éva and Vécsei László and Magyar Kálmán:
The pharmacokinetic evaluation of selegiline ODT for the treatment of Parkinson’s disease.
Expert Opinion on Drug Metabolism and Toxicology, 9 (5).
pp. 629-636.
ISSN 1742-5255
(2013)
Gulyás Balázs and Pavlova Elena and Kása Péter and Gulya Károly and Bakota Lidia and Várszegi Szilvia and Keller Éva and Horváth Mónika Csilla and Nag Sangram and Hermecz Istvá and Magyar Kálmán and Halldin Christer:
Activated MAO-B in the brain of Alzheimer patients, demonstrated by
[11C]-L-deprenyl using whole hemisphere autoradiography.
Neurochemistry International, 58 (1).
pp. 60-68.
ISSN 0197-0186
(2011)
Hollán Zsuzsa and Vécsei László and Magyar Kálmán:
Adverse effects of dopamine potentiation by long-term treatment with selegiline.
MOVEMENT DISORDERS, 19 (1).
pp. 107-109.
ISSN 0885-3185
(2004)